Utilizing a proprietary process, we’re developing the world’s first and only allergen vaccine for poison ivy and poison oak
BOME Therapeutics, is advancing how allergies are treated by developing allergen vaccines that effectively signal the immune system to build tolerance and lower sensitivity to allergens.
Why are we starting with Poison Ivy and Poison Oak?
For over a 100 years, scientists and clinicians have unsuccessfully tried to create a vaccine for poison ivy and poison oak.
Each year, 175 million Americans seek medical attention for poison ivy or oak related allergy issues. For approximately 18 million individuals, avoidance of these plants isn’t practical, making treatment a pressing need as they can suffer highly acute reactions.
BOME Therapeutics is refining an immunotherapy vaccine, which has achieved unparalleled immunity and tolerance to urushiol the allergen produced by poison ivy.
